Advertisement
Home »

Phenotyping of Severe Asthma in the Era of Broad-acting Anti-asthma Biologics.

Jan 29, 2024

ABOUT THE EXPERTS

  • Arnaud Bourdin

    PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France.

    Guy Brusselle

    Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.

    Simon Couillard

    Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC, Canada.

    Merritt L Fajt

    Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

    Liam G Heaney

    Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United Kingdom.

    Elliot Israel

    Pulmonary and Critical Care Medicine, Allergy & Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    P Jane McDowell

    Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United Kingdom.

    Andrew Menzies-Gow

    Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom; Royal Brompton and Harefield Hospitals, School of Immunology & Microbial Sciences, King’s College London, London, United Kingdom.

    Neil Martin

    Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom; University of Leicester, Leicester, United Kingdom.

    Patrick D Mitchell

    School of Medicine, Trinity College Dublin, Dublin, Ireland.

    Nayia Petousi

    Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

    Santiago Quirce

    Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.

    Florence Schleich

    Department of Respiratory Medicine, CHU Liege, GIGA I3 Lab, University of Liege, Liege, Belgium.

    Ian D Pavord

    Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address: ian.pavord@ndm.ox.ac.uk.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement